SCHEMBL7809883

SCHEMBL7809883

CCCCCn1c(N)nc2ncn(CCCCC)c2c1=O

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 5/20 0.47
PDE4A P27815 5/20 0.44
PDE4B Q07343 4/20 0.44
PDE4C Q08493 4/20 0.44
PDE4D Q08499 4/20 0.44
ADORA2B P29275 2/20 0.44
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
ALDH1A1 P00352 1/20 0.44
LMNA P02545 1/20 0.44
ESR1 P03372 1/20 0.44
CYP1A2 P05177 1/20 0.44
MAPT P10636 1/20 0.44
NFKB1 P19838 1/20 0.44
ACHE P22303 1/20 0.44
BLM P54132 1/20 0.44
PMP22 Q01453 1/20 0.44
TLR8 Q9NR97 6/20 0.43
CNOT7 Q9UIV1 4/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2732871 0.87 PDE4A (0.45) ADORA2APDE4APDE4BPDE4CPDE4D
SCHEMBL27762592 0.85 PDE4A (0.41) ADORA2APDE4APDE4BPDE4CPDE4D
SCHEMBL9059983 0.83 PDE4A (0.55) ADORA2APDE4APDE4BPDE4CPDE4D
SCHEMBL4846999 0.75 ADORA2A (0.42) ADORA2APDE4APDE4BPDE4CPDE4D
SCHEMBL26248690 0.75 ADORA2A (0.54) ADORA2APDE4APDE4BPDE4CPDE4D
SCHEMBL11059115 0.73 PDE4A (0.73) ADORA2APDE4APDE4BPDE4CPDE4D
SCHEMBL8522275 0.73 ADORA2B (0.61) ADORA2APDE4APDE4BPDE4CPDE4D
SCHEMBL4849129 0.72 ADORA2A (0.42) ADORA2AKMT2AALDH1A1TLR8
SCHEMBL4850257 0.72 ADORA2A (0.42) ADORA2AKMT2AALDH1A1TLR8
SCHEMBL4846970 0.72 ADORA2A (0.42) ADORA2AKMT2AALDH1A1TLR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0806425-B1 An improved regiospecific process for synthesis of acyclic nucleosides LUPIN LAB LTD (IN) 2001-08-29 EP disclosed
US-6043364-A HEATING THE ISOMER IN AN ALKYLATING AGENT IN ABSENCE OF ACID CATALYST AND SOLVENT LUPIN LABORATORIES LIMITED (IN) 2000-03-28 US disclosed
EP-0976751-A1 A process for the isomerisation of an N-7 isomer into an N-9 isomer useful in the synthesis of acyclic nucleosides LUPIN LABORATORIES LIMITED (IN) 2000-02-02 EP disclosed
US-5821367-A REACTING A DIACYLGUANINE AND AN ALKYLATING AGENT IN THE ABSENCE OF AN ACID CATALYST AND A SOLVENT LUPIN LABORATORIES LIMITED (IN) 1998-10-13 US disclosed
EP-0806425-A1 An improved regiospecific process for synthesis of acyclic nucleosides LUPIN LABORATORIES LIMITED (IN) 1997-11-12 EP disclosed
EP-0806425-A1 An improved regiospecific process for synthesis of acyclic nucleosides LUPIN LABORATORIES LIMITED (IN) 1997-11-12 EP disclosed
CN-1027373-C Therapeutic nucleosides WELLCOME FOUND (GB) 1995-01-11 CN disclosed
CN-1051180-A The nucleosides that is used for the treatment of WELLCOME FOUND (GB) 1991-05-08 CN disclosed
US-4146715-A ANTIVIRAL AGENTS BURROUGHS WELLCOME CO. (US) 1979-03-27 US disclosed